"I believe in using the forces Dr. Bicher (18400 bytes)

of nature to create a medicine which

utilizes these forces -- applying

scientific methods and adapting

them in a natural way -- to harm the

body as little as possible.

Hyperthermia fully meets these criteria."

Haim I.Bicher, M.D.

Founder, Director

Valley Cancer Institute

    A pioneer in the field of hyperthermic oncology with a renowned clinical background in this field, Dr. James Bicher is also internationally recognized for his numerous contributions in basic microcirculation and drug research.

    Dr. James Bicher entered medical school at age 16. He studied under and conducted research with Nobel Prize Laureate Dr. B.A. Houssay. At Jerusalem's Hadassah Medical School, he focused on the effects of blood circulation on cancerous tumors. Upon graduation, he continued his research in Israel and Europe, then came to the United States in 1968. He received his radiation therapy training at Roswell Park Memorial Institute, a major cancer research center, in Buffalo, New York, where he later became associate director of that department .

    Dr. James Bicher is founder and past president of the American Society of Clinical Hyperthermic Oncology (ASCHO) and current president of the International Clinical Hyperthermia Society (ICHO). He is the author of eight published books, and over 200 scientific papers. Recently he edited Consensus on Hyperthermia for the 1990's, a compilation of medical papers from physicians and oncologist worldwide. Dr. Bicher holds seven patents, including components used in hyperthermia.

Top of Page / Home / Treatment Results / Contents

ADENOCARCINOM CANCER / AIDS LYMPHOMA CANCER / BRAIN CANCER TUMOR / SINUS SARCOMA CANCER
  INFLAMMATORY BREAST CANCE TUMOR / PROSTATE CANCER TUMOR / TONSIL CANCER TUMOR / NECK CANCER TUMOR I
NECK CANCER TUMOR II / BREAST CANCER, HEAD and NECK CANCER TUMOR, DEEP TUMORS

 

[Links]
Search engine optimization by SeOS

General Information: inforequest@vci.org

Last modified: May 06, 2008